Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy.
Kuip EJM, Oldenmenger WH, Oomen-de Hoop E, Verduijn GM, Thijs-Visser MF, de Bruijn P, van Meerten E, Koolen SLW, Mathijssen RHJ, van der Rijt CCD. Kuip EJM, et al. Among authors: van meerten e, van der rijt ccd. Cancers (Basel). 2018 Nov 15;10(11):445. doi: 10.3390/cancers10110445. Cancers (Basel). 2018. PMID: 30445772 Free PMC article.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators. Machiels JP, et al. Lancet Oncol. 2024 May;25(5):572-587. doi: 10.1016/S1470-2045(24)00100-1. Epub 2024 Mar 29. Lancet Oncol. 2024. PMID: 38561010 Clinical Trial.
Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: a prospective cross-over drug-drug interaction study.
van der Bol JM, Loos WJ, de Jong FA, van Meerten E, Konings IR, Lam MH, de Bruijn P, Wiemer EA, Verweij J, Mathijssen RH. van der Bol JM, et al. Among authors: van meerten e. Eur J Cancer. 2011 Apr;47(6):831-8. doi: 10.1016/j.ejca.2010.11.030. Epub 2011 Jan 6. Eur J Cancer. 2011. PMID: 21216137 Free article. Clinical Trial.
Nivolumab for Squamous-Cell Cancer of Head and Neck.
Bins S, van Meerten E, Mathijssen RH. Bins S, et al. Among authors: van meerten e. N Engl J Med. 2017 Feb 9;376(6):595-6. doi: 10.1056/NEJMc1615565. N Engl J Med. 2017. PMID: 28181785 No abstract available.
Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable.
Bugter O, van Iwaarden DLP, Dronkers EAC, de Herdt MJ, Wieringa MH, Verduijn GM, Mureau MAM, Ten Hove I, van Meerten E, Hardillo JA, Baatenburg de Jong RJ. Bugter O, et al. Among authors: van meerten e, van iwaarden dlp. Head Neck. 2019 Jun;41(6):1648-1655. doi: 10.1002/hed.25595. Epub 2019 Jan 16. Head Neck. 2019. PMID: 30652377 Free PMC article.
Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study).
Driessen CM, Ham JC, Te Loo M, van Meerten E, van Lamoen M, Hakobjan MH, Takes RP, van der Graaf WT, Kaanders JH, Coenen MJH, van Herpen CM. Driessen CM, et al. Among authors: van meerten e, van lamoen m, van der graaf wt, van herpen cm. Cancers (Basel). 2019 Apr 17;11(4):551. doi: 10.3390/cancers11040551. Cancers (Basel). 2019. PMID: 30999660 Free PMC article.
Comparison of toxicity and effectiveness between fixed-dose and body surface area-based dose capecitabine.
de Man FM, Veerman GDM, Oomen-de Hoop E, Deenen MJ, Meulendijks D, Mandigers CMPW, Soesan M, Schellens JHM, van Meerten E, van Gelder T, Mathijssen RHJ. de Man FM, et al. Among authors: van meerten e, van gelder t. Ther Adv Med Oncol. 2019 Apr 15;11:1758835919838964. doi: 10.1177/1758835919838964. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31019570 Free PMC article.
Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial.
de Boer NL, Brandt-Kerkhof ARM, Madsen EVE, Diepeveen M, van Meerten E, van Eerden RAG, de Man FM, Bouamar R, Koolen SLW, de Hingh IHJT, Bakkers C, Rovers KP, Creemers GM, Deenen MJ, Kranenburg OW, Constantinides A, Mathijssen RHJ, Verhoef C, Burger JWA; Dutch Peritoneal Oncology Group (DPOG); Dutch Colorectal Cancer Group (DCCG). de Boer NL, et al. Among authors: van meerten e, van eerden rag. BMJ Open. 2019 Dec 8;9(12):e034508. doi: 10.1136/bmjopen-2019-034508. BMJ Open. 2019. PMID: 31818845 Free PMC article.
Dissemination patterns and chronology of distant metastasis affect survival of patients with head and neck squamous cell carcinoma.
Berzenji D, Sewnaik A, Keereweer S, Monserez DA, Verduijn GM, van Meerten E, Mast H, Mureau MAM, van der Lugt A, Koljenovic S, Dronkers EAC, Baatenburg de Jong RJ, Hardillo JA. Berzenji D, et al. Among authors: van meerten e, van der lugt a. Oral Oncol. 2021 Aug;119:105356. doi: 10.1016/j.oraloncology.2021.105356. Epub 2021 May 23. Oral Oncol. 2021. PMID: 34034098 Free article.
Relation between body composition and severe diarrhea in patients treated with preoperative chemoradiation with capecitabine for rectal cancer: a single-centre cohort study.
van Rees JM, Hartman W, Nuyttens JJME, Oomen-de Hoop E, van Vugt JLA, Rothbarth J, Verhoef C, van Meerten E. van Rees JM, et al. Among authors: van meerten e, van vugt jla. BMC Gastroenterol. 2021 Aug 4;21(1):313. doi: 10.1186/s12876-021-01886-3. BMC Gastroenterol. 2021. PMID: 34348673 Free PMC article.
62 results